Literature DB >> 15905558

CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection.

Jiaxiang Ji1, Joseph Masterson, Jiaren Sun, Lynn Soong.   

Abstract

Although activation of CD4(+) T cells mediates pathogenesis in Leishmania amazonensis (La)-infected mice, these susceptible mice do not develop a polarized Th2 response, suggesting a unique mechanism of disease susceptibility. To understand how Th cell activities are regulated, we examined the frequency and phenotypes of regulatory T (Treg) cells. At 1-3 wk of infection, relatively high percentages of CD4(+)CD25(+)CD86(+) T cells, as well as high levels of FoxP3, TGF-beta1, and IL-10RI transcripts, were detected in the skin and draining lymph nodes, indicating local accumulation of Treg cells. Lesion-derived, IL-10-producing CD4(+)CD25(+) cells effectively suppressed proliferation and cytokine (IL-2 and IFN-gamma) production of CD4(+)CD25(-) effector cells. Adoptive transfer of lesion-derived CD4(+)CD25(+) cells to syngeneic, naive C57BL/6 mice before infection significantly reduced disease development. To further validate the beneficial role of Treg cells in La infection, we adoptively transferred CD25(+) T cell-depleted splenocytes (derived from naive mice) into RAG1(-/-) mice. This transfer rendered RAG1(-/-) mice more susceptible to La infection than the mice receiving control splenocytes. The beneficial effect of Treg cells was transitory and correlated with decreased activation of IFN-gamma-producing effector T cells. This study uncovers an intriguing role of Treg cells in restraining pathogenic responses during nonhealing Leishmania infection and emphasizes a balance between Treg and Th1-like effector cells in determining the outcome of New World cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905558      PMCID: PMC2812412          DOI: 10.4049/jimmunol.174.11.7147

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.

Authors:  N Noben-Trauth; W E Paul; D L Sacks
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.

Authors:  L Soong; C H Chang; J Sun; B J Longley; N H Ruddle; R A Flavell; D McMahon-Pratt
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

3.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

Authors:  L Soong; J C Xu; I S Grewal; P Kima; J Sun; B J Longley; N H Ruddle; D McMahon-Pratt; R A Flavell
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

4.  Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.

Authors:  N Courret; E Prina; E Mougneau; E M Saraiva; D L Sacks; N Glaichenhaus; J C Antoine
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

5.  Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-gamma but not IL-4 is associated with the development of cutaneous lesions.

Authors:  O Guevara-Mendoza; C Une; P Franceschi Carreira; A Orn
Journal:  Scand J Immunol       Date:  1997-07       Impact factor: 3.487

Review 6.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

7.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

8.  Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice.

Authors:  R M Locksley; S L Reiner; F Hatam; D R Littman; N Killeen
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

9.  Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis.

Authors:  L C Afonso; P Scott
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.

Authors:  R P Almeida; M Barral-Netto; A M De Jesus; L A De Freitas; E M Carvalho; A Barral
Journal:  Am J Trop Med Hyg       Date:  1996-02       Impact factor: 2.345

View more
  49 in total

Review 1.  Regulatory T cells in microbial infection.

Authors:  Jocelyne Demengeot; Santiago Zelenay; Maria Francisca Moraes-Fontes; Iris Caramalho; António Coutinho
Journal:  Springer Semin Immunopathol       Date:  2006-07-28

2.  Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.

Authors:  Nicolas Barros; Nestor Vasquez; Fernando Woll; Cesar Sanchez; Braulio Valencia; Alejandro Llanos-Cuentas; A Clinton White; Martin Montes
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

3.  The Src kinases Hck, Fgr and Lyn activate Arg to facilitate IgG-mediated phagocytosis and Leishmania infection.

Authors:  Dawn M Wetzel; Emma L Rhodes; Shaoguang Li; Diane McMahon-Pratt; Anthony J Koleske
Journal:  J Cell Sci       Date:  2016-06-29       Impact factor: 5.285

4.  CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis.

Authors:  Rong Fang; Nahed Ismail; Thomas Shelite; David H Walker
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Functional changes in regulatory T cells during an experimental infection with sparganum (plerocercofid of Spirometra mansoni).

Authors:  Hyung-Ran Kim; Su-Min Lee; Jong-Wha Won; Woosung Lim; Byung-In Moon; Hyun-Jong Yang; Ju-Young Seoh
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

6.  IL-2 limits IL-12 enhanced lymphocyte proliferation during Leishmania amazonensis infection.

Authors:  Amanda E Ramer-Tait; Christine A Petersen; Douglas E Jones
Journal:  Cell Immunol       Date:  2011-04-09       Impact factor: 4.868

7.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

8.  Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.

Authors:  Nanchaya Wanasen; Lijun Xin; Lynn Soong
Journal:  Int J Parasitol       Date:  2007-09-20       Impact factor: 3.981

9.  FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.

Authors:  Bolaji N Thomas; Laurence U Buxbaum
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

10.  Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype.

Authors:  Amanda E Ramer; Yannick F Vanloubbeeck; Douglas E Jones
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.